Aging Populations And AI Integration Will Expand Gene Therapy Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
10 Aug 25
Updated
16 Aug 25
AnalystHighTarget's Fair Value
US$10.00
94.4% undervalued intrinsic discount16 Aug
US$0.56
1Y
-31.2%7D
8.3%